• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝病中的脂肪悖论

Fat paradox in liver disease.

作者信息

Tsukamoto Hide

机构信息

Department of Pathology, Keck School of Medicine of the University of Southern California and the Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.

出版信息

Keio J Med. 2005 Dec;54(4):190-2. doi: 10.2302/kjm.54.190.

DOI:10.2302/kjm.54.190
PMID:16452829
Abstract

Alcoholic liver disease (ALD) is characterized by accumulation of neutral lipids in hepatocytes leading to micro and macro-vesicular steatosis and balloon cell degeneration. Hypercaloric alimentation and resultant obesity also cause similar changes as evident in non-alcoholic fatty liver disease (NAFLD). Thus, accumulation of lipids in hepatocytes is a pathologic hallmark of ALD and NAFLD. In contrast, quiescent hepatic stellate cells (HSC) are characterized by the intracellular content of not only vitamin A but also triglycerides, and HSC activation is associated with depletion of these lipids. In fact, our recent work demonstrates that adipogenic/ lipogenic transcriptional regulation rendered by PPARgamma, LXRa, and SREBP-1c is essential for the maintenance of the fat-storing, quiescence phenotype of HSC. Expression of these adipogenic transcription factors is lost in activated HSC and the treatment of the cells with the adipocyte differentiation cocktail or ectopic expression of PPARgamma or SREBP-1c causes a reversal of activated cells to the quiescent phenotype. In steatotic livers from ALD and NAFLD mouse models, the expression of these adipogenic transcription factors is induced while the normal control livers lack such expression. Thus, adipogenic regulation is essential for HSC quiescence while it makes hepatocytes steatotic. Interestingly, under the adipogenic conditions of ALD and NAFLD, HSC are still activated to cause fibrosis. This fat paradox in hepatocytes and HSC highlights contrasted significance of fat in these two cell types that depend on each other for their homeostatic control. It further suggests, activated HSC in steatotic livers may have defective insulin signaling or lipogenic regulation.

摘要

酒精性肝病(ALD)的特征是中性脂质在肝细胞中蓄积,导致微泡和大泡性脂肪变性以及气球样细胞变性。高热量饮食及由此导致的肥胖也会引起类似的变化,这在非酒精性脂肪性肝病(NAFLD)中很明显。因此,脂质在肝细胞中的蓄积是ALD和NAFLD的病理标志。相比之下,静止的肝星状细胞(HSC)的特征不仅在于细胞内含有维生素A,还含有甘油三酯,并且HSC激活与这些脂质的消耗有关。事实上,我们最近的研究表明,由PPARγ、LXRα和SREBP-1c介导的脂肪生成/脂质生成转录调控对于维持HSC的脂肪储存静止表型至关重要。这些脂肪生成转录因子的表达在活化的HSC中丧失,用脂肪细胞分化混合物处理细胞或PPARγ或SREBP-1c的异位表达会使活化细胞逆转至静止表型。在ALD和NAFLD小鼠模型的脂肪变性肝脏中,这些脂肪生成转录因子的表达被诱导,而正常对照肝脏则缺乏这种表达。因此,脂肪生成调控对于HSC静止至关重要,而它会使肝细胞发生脂肪变性。有趣的是,在ALD和NAFLD的脂肪生成条件下,HSC仍然被激活以导致纤维化。肝细胞和HSC中的这种脂肪悖论突出了脂肪在这两种相互依赖以维持稳态的细胞类型中的不同意义。这进一步表明,脂肪变性肝脏中的活化HSC可能存在胰岛素信号传导或脂肪生成调控缺陷。

相似文献

1
Fat paradox in liver disease.肝病中的脂肪悖论
Keio J Med. 2005 Dec;54(4):190-2. doi: 10.2302/kjm.54.190.
2
Adipogenic transcriptional regulation of hepatic stellate cells.肝星状细胞的脂肪生成转录调控
J Biol Chem. 2005 Feb 11;280(6):4959-67. doi: 10.1074/jbc.M410078200. Epub 2004 Nov 9.
3
Fat paradox of steatohepatitis.非酒精性脂肪性肝炎的脂肪悖论
J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S104-7. doi: 10.1111/j.1440-1746.2007.05294.x.
4
Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients.高脂饮食诱导的脂肪肝小鼠模型及非酒精性脂肪性肝病患者中肝细胞的脂肪生成变化
Endocrine. 2015 Apr;48(3):834-47. doi: 10.1007/s12020-014-0384-x. Epub 2014 Aug 20.
5
Adipogenic phenotype of hepatic stellate cells.肝星状细胞的脂肪生成表型
Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):132S-133S. doi: 10.1097/01.alc.0000189279.92602.f0.
6
PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.过氧化物酶体增殖物激活受体γ2调节脂肪变性肝细胞中的脂肪生成和脂质积累。
Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1195-205. doi: 10.1152/ajpendo.00513.2004. Epub 2005 Jan 11.
7
Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation.抗脂肪生成调节是肝星状细胞转分化的基础。
J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S102-5. doi: 10.1111/j.1440-1746.2006.04573.x.
8
Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts.由肝细胞和巨噬细胞特异性条件性敲除确定 PPARγ 在肥胖诱导的肝脂肪变性中的作用。
FASEB J. 2011 Aug;25(8):2538-50. doi: 10.1096/fj.10-173716. Epub 2011 Apr 19.
9
Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.促甲状腺素通过上调 SREBP-1c 活性增加肝内甘油三酯含量。
J Hepatol. 2014 Dec;61(6):1358-64. doi: 10.1016/j.jhep.2014.06.037. Epub 2014 Jul 10.
10
Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.细胞特异性过氧化物酶体增殖物激活受体 γ 缺失赋予非实质细胞中该核受体抗炎和抗纤维化特性。
J Hepatol. 2013 Nov;59(5):1045-53. doi: 10.1016/j.jhep.2013.06.023. Epub 2013 Jul 2.

引用本文的文献

1
100% Fish oil-based lipid emulsion inhibits hepatic stellate cell activation via suppression of the TGF-β1 autocrine signaling.100%基于鱼油的脂质乳剂通过抑制转化生长因子-β1自分泌信号传导来抑制肝星状细胞活化。
Hum Cell. 2025 Aug 27;38(5):153. doi: 10.1007/s13577-025-01283-y.
2
Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression.酒精性肝病的结局:肝损伤进展的关键机制
Biomolecules. 2024 Mar 27;14(4):404. doi: 10.3390/biom14040404.
3
Resveratrol increases the activation markers and changes the release of inflammatory cytokines of hepatic stellate cells.
白藜芦醇增加肝星状细胞的激活标志物,并改变其炎症细胞因子的释放。
Mol Cell Biochem. 2021 Feb;476(2):649-661. doi: 10.1007/s11010-020-03933-1. Epub 2020 Oct 19.
4
Mechanistic insights into the effects of SREBP1c on hepatic stellate cell and liver fibrosis.深入了解 SREBP1c 对肝星状细胞和肝纤维化的影响的机制。
J Cell Mol Med. 2020 Sep;24(17):10063-10074. doi: 10.1111/jcmm.15614. Epub 2020 Jul 17.
5
Characterization of the Roles of Vimentin in Regulating the Proliferation and Migration of HSCs during Hepatic Fibrogenesis.探讨波形蛋白在调控肝纤维化过程中造血干细胞增殖和迁移中的作用。
Cells. 2019 Oct 1;8(10):1184. doi: 10.3390/cells8101184.
6
Quantitative Proteomic analysis on Activated Hepatic Stellate Cells reversion Reveal STAT1 as a key regulator between Liver Fibrosis and recovery.定量蛋白质组学分析激活的肝星状细胞逆转揭示 STAT1 是肝纤维化和恢复之间的关键调节因子。
Sci Rep. 2017 Mar 21;7:44910. doi: 10.1038/srep44910.
7
New Approaches for Studying Alcoholic Liver Disease.研究酒精性肝病的新方法
Curr Pathobiol Rep. 2014 Dec;2(4):171-183. doi: 10.1007/s40139-014-0053-z. Epub 2014 Sep 14.
8
Bone marrow-derived fibrocytes contribute to liver fibrosis.骨髓来源的纤维细胞促成肝纤维化。
Exp Biol Med (Maywood). 2015 Jun;240(6):691-700. doi: 10.1177/1535370215584933. Epub 2015 May 12.
9
Contribution of bone marrow-derived fibrocytes to liver fibrosis.骨髓源性成纤维细胞在肝纤维化中的作用。
Hepatobiliary Surg Nutr. 2015 Feb;4(1):34-47. doi: 10.3978/j.issn.2304-3881.2015.01.01.
10
The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies.导致不同病因肝纤维化的肝肌成纤维细胞类型。
Front Pharmacol. 2014 Jul 22;5:167. doi: 10.3389/fphar.2014.00167. eCollection 2014.